Home・Akcijų sąrašas・OPKO Health Inc

OPKO Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

1.36

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1.35

Max

1.38

Pagrindiniai rodikliai
By Trading Economics
Pajamos	46M -8.4M
Pardavimai	39M 164M
Pelnas, tenkantis vienai akcijai	-0.01
Pelno marža	-5.145
Darbuotojai	2,275
EBITDA	40M 12M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+120.59% upside

Dividendai
By Acuity
Kitas uždarbis	2026-10-28

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	131M 1B
Ankstesnė atidarymo kaina	1.36
Ankstesnė uždarymo kaina	1.36

Naujienos nuotaikos

By Acuity

50%

154 / 340 reitingas Healthcare

OPKO Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-17 19:06; UTC

News

OPKO Health Inc. shares are lower today, continuing a decline since Friday. The company issued $125 million in senior secured notes linked to mazdutide royalties.

2026-08-14 19:36; UTC

OPKO Health Inc shares are lower amid broader market concerns following a reported decline in retail sales for July. The stock reached a session low earlier.

2026-08-13 23:01; UTC

OPKO Health shares lower in after-market trading, declining since Thursday's close amid mixed macroeconomic signals and uncertainty in the market.

2026-08-12 19:36; UTC

OPKO Health Inc shares are modestly higher, reflecting a positive market environment amid recent risk asset gains. Core CPI data aligns with forecasts, supporting steady interest rates.

2026-08-11 19:36; UTC

OPKO Health Inc shares are higher, maintaining a position above their 20-day moving average amid broader market sentiment influenced by geopolitical tensions and inflation reports.

2026-08-10 19:46; UTC

OPKO Health Inc. shares are trading higher amid broader market uncertainty, reflecting notable strength above its 20-day moving average since Friday's close.

2026-08-07 23:01; UTC

OPKO Health shares advanced in after-market trading, recovering from earlier losses amid broader market dynamics and a slight decline in the unemployment rate.

2026-08-06 19:16; UTC

OPKO Health Inc. shares are lower today amid notable volatility, with economic data showing initial jobless claims rose slightly ahead of tomorrow's non-farm payrolls report.

2026-08-05 23:01; UTC

OPKO Health shares are lower in after-market hours, reflecting broader market weakness amid recent economic data showing weaker-than-expected U.S. job growth.

2026-08-04 23:06; UTC

OPKO Health Inc. shares are higher in after-market trading, settling with a cumulative gain following a brief dip at the session's start.

2026-08-03 23:01; UTC

OPKO Health Inc shares increased in after-market trading, maintaining a steady rise since Monday's close amid a generally positive market backdrop.

2026-07-31 19:45; UTC

OPKO Health Inc. shares are trading roughly flat today, hovering around the middle of their one-month range and above the 20-day moving average.

2026-07-30 23:11; UTC

OPKO Health Inc. shares are lower in after-market hours, continuing a recent trend amid broader market uncertainty following the Federal Reserve's interest rate decision.

2026-07-29 23:46; UTC

No specific news was identified for OPKO Health Inc. Shares remained roughly flat during after-market hours, trading near unchanged since Wednesday's close.

2026-07-28 23:41; UTC

News

OPKO Health reported a narrowed net loss of $8.4 million and raised revenue guidance, but shares are lower in after-market hours following recent gains.

2026-07-27 23:41; UTC

News

OPKO Health reported second-quarter revenues of $163.5 million, surpassing expectations. The company also raised its full-year sales guidance, boosting shares in after-market trading.

2026-07-24 22:06; UTC

OPKO Health Inc shares are higher in after-market trading, reaching a peak shortly after the market closed. No specific news was identified for this movement.

2026-07-22 18:31; UTC

OPKO Health is declining today, having pulled back from earlier gains amid broader market volatility and rising geopolitical tensions.

2026-07-21 22:56; UTC

No specific news was identified for OPKO Health during after-market hours. The stock remains roughly flat, positioned 12.60% below its 20-day moving average.

2026-07-20 19:51; UTC

OPKO Health Inc shares are higher in Monday's session, reflecting positive trading conditions. Broader market dynamics are supported by strength in Asian markets.

Akcijų palyginimas

Kainos pokytis

OPKO Health Inc Prognozė

Kainos tikslas

By TipRanks

120.59% į viršų

12 mėnesių prognozė

Vidutinis 3 USD 120.59%

Aukščiausias 3 USD

Žemiausias 3 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines OPKO Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių OPKO Health Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Rinkos nuotaikos

By Acuity

154 / 340 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę OPKO Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida.